Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryo Hatano

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Biological Chemistry|May 8, 2010
A novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubulesKatsuko Shiraya, Taku Hirata, Ryo Hatano, et al.
International Journal of Molecular Sciences|September 13, 2019
Diet-Induced Obese Mice and Leptin-Deficient <i>Lep<sup>ob/ob</sup></i> Mice Exhibit Increased Circulating GIP Levels Produced by Different MechanismsEunyoung Lee, Emily L Miedzybrodzka, Xilin Zhang, et al.
Cell Death & Disease|May 22, 2021
IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cellsTakumi Itoh, Ryo Hatano, Yoshiya Horimoto, et al.
International Immunology|October 9, 2024
An abnormal increase in CD26(-)CD28(-) cytotoxic effector CD4 and CD8 T cell populations in patients with systemic lupus erythematosusRyo Hatano, Hayato Nakamura, Ayako Yamamoto, et al.
Cells|August 26, 2023
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell MalignanciesEiji Kobayashi, Yusuke Kamihara, Miho Arai, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 23, 2026
Identification of a Highly Functional Effector CD8<sup>+</sup> T Cell Program after Transplantation in Mice and HumansRiley P Leathem, Joel S Freibaum, Gregory S Cohen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2022
Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host diseaseRyo Hatano, Takumi Itoh, Haruna Otsuka, et al.
Nature Communications|September 15, 2022
Liver group 2 innate lymphoid cells regulate blood glucose levels through IL-13 signaling and suppression of gluconeogenesisMasanori Fujimoto, Masataka Yokoyama, Masahiro Kiuchi, et al.
Nature Medicine|August 5, 2020
Single-cell atlas of colonic CD8<sup>+</sup> T cells in ulcerative colitisDaniele Corridoni, Agne Antanaviciute, Tarun Gupta, et al.
Scientific Reports|December 4, 2019
DPP8 is a novel therapeutic target for multiple myelomaTsutomu Sato, Ayumi Tatekoshi, Kohichi Takada, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Biological Chemistry|May 8, 2010
A novel transporter of SLC22 family specifically transports prostaglandins and co-localizes with 15-hydroxyprostaglandin dehydrogenase in renal proximal tubulesKatsuko Shiraya, Taku Hirata, Ryo Hatano, et al.
International Journal of Molecular Sciences|September 13, 2019
Diet-Induced Obese Mice and Leptin-Deficient <i>Lep<sup>ob/ob</sup></i> Mice Exhibit Increased Circulating GIP Levels Produced by Different MechanismsEunyoung Lee, Emily L Miedzybrodzka, Xilin Zhang, et al.
Cell Death & Disease|May 22, 2021
IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cellsTakumi Itoh, Ryo Hatano, Yoshiya Horimoto, et al.
International Immunology|October 9, 2024
An abnormal increase in CD26(-)CD28(-) cytotoxic effector CD4 and CD8 T cell populations in patients with systemic lupus erythematosusRyo Hatano, Hayato Nakamura, Ayako Yamamoto, et al.
Cells|August 26, 2023
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell MalignanciesEiji Kobayashi, Yusuke Kamihara, Miho Arai, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 23, 2026
Identification of a Highly Functional Effector CD8<sup>+</sup> T Cell Program after Transplantation in Mice and HumansRiley P Leathem, Joel S Freibaum, Gregory S Cohen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2022
Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host diseaseRyo Hatano, Takumi Itoh, Haruna Otsuka, et al.
Nature Communications|September 15, 2022
Liver group 2 innate lymphoid cells regulate blood glucose levels through IL-13 signaling and suppression of gluconeogenesisMasanori Fujimoto, Masataka Yokoyama, Masahiro Kiuchi, et al.
Nature Medicine|August 5, 2020
Single-cell atlas of colonic CD8<sup>+</sup> T cells in ulcerative colitisDaniele Corridoni, Agne Antanaviciute, Tarun Gupta, et al.
Scientific Reports|December 4, 2019
DPP8 is a novel therapeutic target for multiple myelomaTsutomu Sato, Ayumi Tatekoshi, Kohichi Takada, et al.
Pageof 9